Bernard Klonjkowski

1.8k total citations
47 papers, 1.3k citations indexed

About

Bernard Klonjkowski is a scholar working on Genetics, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Bernard Klonjkowski has authored 47 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 14 papers in Molecular Biology and 13 papers in Infectious Diseases. Recurrent topics in Bernard Klonjkowski's work include Virus-based gene therapy research (25 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and Viral gastroenteritis research and epidemiology (5 papers). Bernard Klonjkowski is often cited by papers focused on Virus-based gene therapy research (25 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and Viral gastroenteritis research and epidemiology (5 papers). Bernard Klonjkowski collaborates with scholars based in France, Belgium and United Kingdom. Bernard Klonjkowski's co-authors include Mathias Mericskay, Elisabeth Tournier‐Lasserve, Zhenlin Li, Anne Joutel, Eliane Berrou, Pierre Lacombe, Jacqueline Maciazek, Luke T. Krebs, Valérie Domenga and Thomas Gridley and has published in prestigious journals such as Genes & Development, PLoS ONE and Cancer Research.

In The Last Decade

Bernard Klonjkowski

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Klonjkowski France 16 495 453 301 202 180 47 1.3k
M. Fernández de Marco United Kingdom 19 237 0.5× 224 0.5× 105 0.3× 63 0.3× 155 0.9× 23 830
S. Tateyama Japan 21 196 0.4× 140 0.3× 216 0.7× 124 0.6× 116 0.6× 60 1.1k
Vanessa Herder Germany 19 154 0.3× 402 0.9× 104 0.3× 69 0.3× 146 0.8× 47 1.2k
Anne Eugster United States 24 586 1.2× 230 0.5× 527 1.8× 33 0.2× 117 0.7× 78 1.7k
Y. Iwasaki Japan 21 250 0.5× 206 0.5× 163 0.5× 156 0.8× 62 0.3× 49 1.4k
Lucinda Hensley United States 20 618 1.2× 545 1.2× 139 0.5× 57 0.3× 93 0.5× 27 1.9k
Seii Ohka Japan 19 412 0.8× 395 0.9× 251 0.8× 25 0.1× 78 0.4× 44 1.2k
Ana Alcaraz United States 15 603 1.2× 172 0.4× 122 0.4× 28 0.1× 111 0.6× 32 1.5k
Donna L. Mallery United Kingdom 24 1.4k 2.9× 776 1.7× 402 1.3× 238 1.2× 89 0.5× 29 2.9k
Darrell WuDunn United States 27 669 1.4× 174 0.4× 619 2.1× 104 0.5× 165 0.9× 69 3.7k

Countries citing papers authored by Bernard Klonjkowski

Since Specialization
Citations

This map shows the geographic impact of Bernard Klonjkowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Klonjkowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Klonjkowski more than expected).

Fields of papers citing papers by Bernard Klonjkowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Klonjkowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Klonjkowski. The network helps show where Bernard Klonjkowski may publish in the future.

Co-authorship network of co-authors of Bernard Klonjkowski

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Klonjkowski. A scholar is included among the top collaborators of Bernard Klonjkowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Klonjkowski. Bernard Klonjkowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khan, Mohammad Kalim Ahmad, Christopher S. von Bartheld, Sandra Martin‐Latil, et al.. (2025). Omicron Impacts Olfaction in Hamsters. The FASEB Journal. 39(14). e70879–e70879. 1 indexed citations
2.
Beaud, Georges, Bernard Klonjkowski, François Piumi, et al.. (2024). Vaccinia Virus Defective Particles Lacking the F17 Protein Do Not Inhibit Protein Synthesis: F17, a Double-Edged Sword for Protein Synthesis?. International Journal of Molecular Sciences. 25(3). 1382–1382. 2 indexed citations
3.
4.
Barre, Annick, Els J. M. Van Damme, Bernard Klonjkowski, et al.. (2022). Legume Lectins with Different Specificities as Potential Glycan Probes for Pathogenic Enveloped Viruses. Cells. 11(3). 339–339. 13 indexed citations
5.
Costa, Bruno R. da, et al.. (2022). Neutrophils play a major role in the destruction of the olfactory epithelium during SARS-CoV-2 infection in hamsters. Cellular and Molecular Life Sciences. 79(12). 616–616. 22 indexed citations
6.
Cecon, Erika, Daniela Fernandois, Nicolas Renault, et al.. (2022). Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels. Cellular and Molecular Life Sciences. 79(7). 361–361. 24 indexed citations
7.
Cecon, Erika, Sophie Le Poder, Fernando Real, et al.. (2021). Therapeutic potential of melatonin and melatonergic drugs on K18‐hACE2 mice infected with SARS‐CoV‐2. Journal of Pineal Research. 72(1). e12772–e12772. 24 indexed citations
8.
Barre, Annick, Els J. M. Van Damme, Sophie Le Poder, et al.. (2021). Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives. Cells. 10(7). 1619–1619. 32 indexed citations
9.
Gantzer, Murielle, Johann Foloppe, Bernard Klonjkowski, et al.. (2021). Safety, biodistribution and viral shedding of oncolytic vaccinia virus TG6002 administered intravenously in healthy beagle dogs. Scientific Reports. 11(1). 2209–2209. 7 indexed citations
10.
Kohlhauer, Matthias, Eve Laloy, Éric Quéméneur, et al.. (2021). Pharmacokinetics and tolerance of repeated oral administration of 5-fluorocytosine in healthy dogs. BMC Veterinary Research. 17(1). 220–220. 4 indexed citations
11.
Jouneau, Luc, David Lefebvre, Aurore Romey, et al.. (2020). The antibody response induced FMDV vaccines in sheep correlates with early transcriptomic responses in blood. npj Vaccines. 5(1). 1–1. 78 indexed citations
12.
Feghoul, Linda, Séverine Mercier‐Delarue, Maud Salmona, et al.. (2018). Genetic diversity of the human adenovirus species C DNA polymerase. Antiviral Research. 156. 1–9. 3 indexed citations
13.
Zhou, Xiaocui, David Lefebvre, Sandrine Lacour, et al.. (2018). A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs. Vaccine. 36(16). 2193–2198. 11 indexed citations
14.
15.
Contreras, Vanessa, Marion Szelechowski, Cyril Viarouge, et al.. (2014). Expression of VP7, a Bluetongue Virus Group Specific Antigen by Viral Vectors: Analysis of the Induced Immune Responses and Evaluation of Protective Potential in Sheep. PLoS ONE. 9(11). e111605–e111605. 17 indexed citations
16.
17.
Domenga, Valérie, Pierre Lacombe, Jacqueline Maciazek, et al.. (2004). Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes & Development. 18(22). 2730–2735. 415 indexed citations
18.
Mouthon, Franck, et al.. (2001). Nervous and Nonnervous Cell Transduction by Recombinant Adenoviruses That Inducibly Express the Human PrP. Biochemical and Biophysical Research Communications. 285(3). 623–632. 6 indexed citations
19.
Klonjkowski, Bernard. (1998). Molecular and cellular biology of gene therapy. Virologie. 2(3). 4 indexed citations
20.
Klonjkowski, Bernard, Pascale Gilardi‐Hebenstreit, Juliette Hadchouel, et al.. (1997). A Recombinant E1-Deleted Canine Adenoviral Vector Capable of Transduction and Expression of a Transgene in Human-Derived Cells and In Vivo. Human Gene Therapy. 8(17). 2103–2115. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Fernández de Marco Breakdown of academic impact, for papers by S. Tateyama Breakdown of academic impact, for papers by Vanessa Herder Breakdown of academic impact, for papers by Anne Eugster Breakdown of academic impact, for papers by Y. Iwasaki Breakdown of academic impact, for papers by Lucinda Hensley Breakdown of academic impact, for papers by Seii Ohka Breakdown of academic impact, for papers by Ana Alcaraz Breakdown of academic impact, for papers by Donna L. Mallery Breakdown of academic impact, for papers by Darrell WuDunn
Rankless by CCL
2026